Alivus Life Sciences Limited has informed the Exchange about General Updates
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences has received an order from the Office of Commissioner of Customs NS II (Jawaharlal Nehru Custom House, Nhava Sheva) dated August 19, 2025, alleging mis-classification of goods. The order imposes a differential export incentive (MEIS) recovery of Rs. 6.54 lakh under Section 28(4)/28AAA of the Customs Act along with interest, a redemption fine of Rs. 3 crore under Section 125, and penalties of Rs. 5 lakh each under three separate sections (114(iii), 114AA, and 114AB), totaling Rs. 15 lakh in penalties. The company has stated there is no material impact on its financials, operations, or other activities. The order is appealable, and Alivus is evaluating whether to file an appeal.
While the total penalty and fine amount to around Rs. 3.21 crore, the company has explicitly classified this as non-material to its financials. Shareholders should watch for an update on whether the company appeals the order, as a negative appellate outcome could change the assessment. Near-term share price impact is likely limited given the company's own 'no material impact' disclosure.